Evaxion Biotech A/S (EVAX) Earning

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.03
Day's range
$3.28

Evaxion A/S Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2026 2 -$0.02 -$0.00 -$0.01
Q2 2026 1 -$0.01 -$0.01 -$0.01
Q3 2026 1 -$0.01 -$0.01 -$0.01
Q4 2026 1 -$0.01 -$0.01 -$0.01
Q1 2027 1 -$0.37 -$0.37 -$0.37
Q2 2027 1 -$0.39 -$0.39 -$0.39
Q3 2027 1 -$0.42 -$0.42 -$0.42
Q4 2027 1 -$0.33 -$0.33 -$0.33
Q1 2028 1 -$10.75 -$10.75 -$10.75
Q2 2028 1 -$9.50 -$9.50 -$9.50
Q3 2028 1 -$8.00 -$8.00 -$8.00
Q4 2028 1 -$5.48 -$5.48 -$5.48
Q1 2029 1 -$1.27 -$1.27 -$1.27
Q2 2029 1 -$1.57 -$1.57 -$1.57
Q3 2029 1 -$1.96 -$1.96 -$1.96
Q4 2029 1 -$0.01 -$0.01 -$0.01
Q1 2030 1 -$1.96 -$1.96 -$1.96
Q2 2030 1 -$0.01 -$0.01 -$0.01
Q3 2030 1 -$0.01 -$0.01 -$0.01
Q4 2030 1 -$0.01 -$0.01 -$0.01
Q1 2031 1 -$0.01 -$0.01 -$0.01

Evaxion A/S Earnings Date And Information

Evaxion A/S last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.44 earnings per share for the quarter, missing analysts' consensus estimates of $-0.01 by $0.43. The company had revenue of 0 for the quarter and had revenue of 7.53 M for the year. Evaxion A/S has generated $-1 earnings per share over the last year ($-1.21 diluted earnings per share) and currently has a price-to-earnings ratio of -3.58. Evaxion A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.

Evaxion A/S Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
03/05/2026 Q4 2025 -$0.25 -$0.89 -0.65 $7.50 M $0
09/30/2025 Q3 2025 N/A $4.20 N/A $3.75 M $7.49 M
08/14/2025 Q2 2025 -$0.50 -$4.40 -3.9 $8.00 M $37.00 K
03/31/2025 Q1 2025 N/A -$1.43 N/A $60.00 K $0
04/01/2025 Q4 2024 N/A -$3.40 N/A $1.66 M $122.00 K
09/30/2024 Q3 2024 N/A -$1.40 N/A $123.33 K $3.02 M
06/30/2024 Q2 2024 N/A -$4.60 N/A $52.00 K $154.00 K
08/14/2024 Q1 2024 $0.10 $1.04 0.94 $37.00 K $51.00 K
03/26/2024 Q4 2023 N/A -$6.60 N/A N/A $73.00 K
09/30/2023 Q3 2023 N/A -$8.20 N/A N/A $0
08/17/2023 Q2 2023 N/A -$8.40 N/A N/A $0
03/31/2023 Q1 2023 N/A -$9.68 N/A N/A $0
04/27/2023 Q4 2022 N/A -$11.40 N/A N/A $0
11/13/2022 Q3 2022 -$17.00 -$9.64 7.36 N/A $0
06/30/2022 Q2 2022 N/A -$8.20 N/A N/A $0
03/31/2022 Q1 2022 N/A -$10.00 N/A N/A $0
03/31/2022 Q4 2021 N/A -$15.44 N/A N/A $0
09/30/2021 Q3 2021 N/A -$10.92 N/A N/A $0
06/30/2021 Q2 2021 N/A -$14.40 N/A N/A $0
03/31/2021 Q1 2021 N/A -$9.20 N/A N/A $0

Evaxion A/S Earnings: FAQ's

The conference call for Evaxion A/S's latest earnings report can be listened to online.

The conference call transcript for Evaxion A/S's latest earnings report can be read online.

Evaxion A/S (:EVAX) has a recorded annual revenue of $7.53 M.

Evaxion A/S (:EVAX) has a recorded net income of $-7,707,000.Evaxion A/S has generated $-1.21 earnings per share over the last four quarters.

Evaxion A/S (:EVAX) has a price-to-earnings ratio of -3.58 and price/earnings-to-growth ratio is -0.06.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED